Literature DB >> 8194471

Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts.

A Zapf1, D Hsu, J M Olefsky.   

Abstract

In this study we have compared the intracellular itineraries of insulin and insulin-like growth factor-I (IGF-I) and their receptors subsequent to ligand internalization in rat fibroblasts. We found that the endocytic rate constant is approximately 3 times as high for insulin as for IGF-I. The dissociation of internalized ligand from its receptor was monitored by the ability of ligand-receptor complexes to precipitate in the presence of polyethylene glycol (PEG). Insulin loses its ability to precipitate with PEG more rapidly than IGF-I. After 60 min, less than 10% of the intracellular insulin remains PEG precipitable, whereas 44% of intracellular IGF-I stays PEG precipitable. Ligand degradation was determined by precipitation with trichloroacetic acid (TCA). Insulin degradation after internalization is more rapid compared with IGF-I degradation; after 2 h, 80% of intracellular IGF-I, in contrast to only 30% of intracellular insulin, remains intact. We measured retroendocytosis of insulin and IGF-I by assessing the amount of internalized ligand that was subsequently released from the cells. When analyzing released ligand by TCA precipitation, we found that 25% of insulin and 53% of IGF-I were TCA precipitable. After 120 min, only 16% of insulin and 43% of IGF-I remained intracellular. To provide insight into a possible mechanism that prevents IGF-I from being subjected to the same degree of degradation as insulin, we studied the effect of pH on IGF-I and insulin binding. We found IGF-I binding to be less sensitive to decreases in pH compared with insulin binding. Therefore, it is likely that after internalization, IGF-I does not dissociate from its intracellular receptor as easily as insulin in the acidifying endosome and, therefore, can return to the cell surface via a recycling receptor. In summary, we have observed distinct differences in the intracellular itineraries of IGF-I and insulin and their receptors. IGF-I internalization and degradation proceed less efficiently than insulin internalization, and IGF-I is preferentially targeted into a retroendocytotic pathway in contrast to insulin, which primarily undergoes lysosomal degradation. The differential effect of pH on ligand binding to these structurally related hormone receptors may account for the quantitatively distinct ligand trafficking events.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194471     DOI: 10.1210/endo.134.6.8194471

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.

Authors:  R D York; D C Molliver; S S Grewal; P E Stenberg; E W McCleskey; P J Stork
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 2.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

3.  Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus.

Authors:  Phu V Tran; Stephanie J B Fretham; Jane Wobken; Bradley S Miller; Michael K Georgieff
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-16       Impact factor: 4.310

4.  Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.

Authors:  Alaide Morcavallo; Marco Genua; Angela Palummo; Emilia Kletvikova; Jiri Jiracek; Andrzej M Brzozowski; Renato V Iozzo; Antonino Belfiore; Andrea Morrione
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

5.  Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization.

Authors:  A E Lenferink; R H Kramer; M J van Vugt; M Königswieser; P P Di Fiore; E J van Zoelen; M L van de Poll
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.

Authors:  B F Hansen; G M Danielsen; K Drejer; A R Sørensen; F C Wiberg; H H Klein; A G Lundemose
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

7.  Different binding and degradation of proinsulin, insulin and insulin-like growth factor-1 (IGF-1) in cultured renal proximal tubular cells. Implications for the prolonged serum half-life of proinsulin.

Authors:  P M Jehle; R D Fussgänger; S Stracke; R W Grunewald; F Keller
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

8.  Myoferlin is required for insulin-like growth factor response and muscle growth.

Authors:  Alexis R Demonbreun; Avery D Posey; Konstantina Heretis; Kayleigh A Swaggart; Judy U Earley; Peter Pytel; Elizabeth M McNally
Journal:  FASEB J       Date:  2009-12-11       Impact factor: 5.191

Review 9.  Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.

Authors:  M Hamoudane; S Maffioli; R Cordera; D Maggi; B Salani
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

10.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.